Dr. Hersh and colleagues have begun to analyze data from their patients who underwent CXL as part of an FDA clinical trial in order to devise a CXL algorithm. The article below was published in the June 1, 2012 issue of Ophthalmology Times.
At the CLEI Center for Keratoconus, Dr. Hersh and his staff are involved in a number of educational programs for keratoconus doctors and patients. In the Fall of 2012, we will sponsor our 8th Annual Keratoconus Patient Symposium in association with the National Keratoconus Foundation. In a very successful program last year, nearly 150 keratoconus… Read More